Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Sci Rep. 2020 Oct 23;10(1):18504. doi: 10.1038/s41598-020-74206-6.

Ming-Jenn Chen^{1

2}, De-Wei Wu³, Yao-Chen Wang^{4

5}, Chi-Yi Chen⁶, Huei Lee⁷

¹ Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan.
² Department of Sports Management, College of Leisure and Recreation Management, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.
³ Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan.
⁴ School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁵ Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁶ Department of Surgery, Chung Shan Medical University, Taichung, Taiwan.
⁷ Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan. hl@tmu.edu.tw.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.